
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Danny R. Johnson, RPh, explains the impact he expects the Civic Leader of the Year award to have on his pharmacy career.
Danny R. Johnson, RPh, explains the impact he expects the Civic Leader of the Year award to have on his pharmacy career.






